期刊文献+

锂盐的作用机制及临床应用研究进展 被引量:6

Research Progress of Lithium Salt on Pathogenesis and Clinical Applications
原文传递
导出
摘要 锂是人体内的一种微量元素且以化合物的形式广泛存在于自然界。作为一种古老的治疗精神疾病方面的药物,锂盐被用来治疗双相情感障碍已超过60年,而现在锂盐在临床上表现出来的新应用已经越来越引起医学界的广泛重视。现代研究表明,锂盐是一种强大的糖原合成酶激酶-3(GSK-3β)抑制剂,锂盐除对脑细胞过度活动起抑制作用外,还具有营养神经和保护神经、抗炎、抗氧化、抗癌、免疫调节以及对甲状腺功能亢进的治疗作用。锂盐化学结构相对简单,而且目前人们对锂盐的使用经验及对锂离子的血药浓度监测手段已日趋成熟,所以锂盐具有相当好的临床应用前景,未来更进一步加大对锂盐的临床应用及作用机制的研究力度。现就锂盐新发现的作用机制及临床应用作一综述。 Lithium is a trace element in the human body and by means of compounds widely exists in nature. As an old drug for the treatment of mental disorders, lithium salt has been used as a therapeutic agent for bipolar disorder more than 60 years, but now, lithium has caused increasingly wide attention in the medical world for its new clinical applications. Modern researches indicate that lithium salt is one king of powerful glycogen synthase kinase-3(GSK-3β) inhibitor, lithium salt doesn't only inhibit excessive brain activity, but also has neurotrophic and neuroprotective activity, antioxidant activity, anti-inflammatory activity, anticancer activity, immune regulation and treatment of hyperthyroidism. The chemical structure of lithium salt is relatively simple, and people's using experience and blood drug concentration monitoring method have becoming more matured, so lithium's clinical application prospects are pretty good, we should increase the study of clinical application and mechanism of action of lithium. The relevant research progress on pathogenesis and clinical applications is to be reviewed.
出处 《现代生物医学进展》 CAS 2015年第29期5762-5764,5712,共4页 Progress in Modern Biomedicine
基金 国家自然科学基金项目(30500544) 教育部长江学者和创新团队发展计划(IRT09350) 四川省科技厅支撑项目(12ZCO909)
关键词 锂盐 作用机制 临床应用 Lithium Salt Pathogenesis Clinical Application
  • 相关文献

参考文献33

  • 1Shorter E. The history of lithium threrapy[J]. Bipolar Disord, 2009, 11 (Suppl 2):4-9.
  • 2Malhi GS, Tanious M, Das P, et al. Potential mechanisms of action of lithium in bipolar disorder. Current understanding [J]. CNS Drugs, 2013, 27(2): 135-153.
  • 3Aubry JM, Schwald M, BaUmann E, et al. Early effects of mood stabi- lizers on the Akt / GSK-3beta signaling pathway and on cell survival and proliferation [J]. Psychopharmacology (Bed), 2009, 205 (3): 419-429.
  • 4Hashimoto R, Takei N. Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons:all essential step for neuroprotection against glutamate excitotoxicity [J]. Neurophar- macol, 2002, 43(7): 1173-1179.
  • 5Hammonds MD, Shim SS. Effects of 4-week treatment with lithium and olanzapine on levels of brain-derived neurotrophic factor, B-cell CLL/lymphoma2 and phosphorylated cyclic adenosine monophos- phate response element-binding protein in the sub-regions of the hip- pocampus[J]. Basic Clin Pharmacol, 2009, 105(2): 113-119.
  • 6Albayrak A, Halici Z, Polat B, et al. Protective effects of lithium: a new look at an old drug with potential antioxidative and anti-inflam- matory effects in an animal model of sepsis[J]. Int Immunopharmacol,2013, 16(1):35-40.
  • 7Beurel E, Jope RS. Glycogen synthase kinase-3 regulates inflammatory tolerance in astrocytes[J]. Neuroscience, 2010, 169(3): 1063-1070.
  • 8Salvemini D, Wang ZQ, Wyatt PS. Nitric oxide: a key mediator in the early and late phase ofcarrageenan-induced rat paw inflammation[J]. Br J Pharmacol, 1996, 118(4):829-838.
  • 9Oruch R, Elderbi MA, Khattab HA, et al. Lithium: a review of pharma- cology, clinical uses, and toxicity [J]. Eur J Pharmacol, 2014, 740(5): 464-473.
  • 10Scheuing L, Chiu CT, Liao HM, et al. Preclinical and clinical investi- gations of mood stabilizers for Huntington's disease: what have we learned? [J]. International Journal of Biological Science, 2014, 10(9): 1024-1038.

二级参考文献10

  • 1Frey BN, Valvassori SS. Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania[J]. Psychiatry Neurosci, 2006, 31 (5) : 326- 332.
  • 2Bonazzola P, Egido P. Lithium and KB-R7943 effects on mechanics and energetics of rat heart muscle[J]. Acta Physiol Scand,2002,176 (1) : 1-11.
  • 3Mozaffari MS, Schaffer SW. Effect of pressure overload on cardioprotection of mitochondrial KATP channels and GSK- 3beta:interaction with the MPT pore[J]. Am J Hypertens, 2008,21 (5) : 570-580.
  • 4McCord JM. Oxygen-derived free radicals in postisehemia tissue injury[J].N Engl J Med, 1985,312(3) : 159-163.
  • 5Wilot LC, Bemardi A, Frozza RL, et al. Lithium and valproate protect hippocampal slices against ATP-induced cell death[J].Neurochem Res,2007,32(9) : 1539-1546.
  • 6Shalbuyeva N, Brustovetsky T, Brustovetsky N. Lithium desensitizes brain mitochondria to calcium, antagonizes permeability transition, and diminishes eytochrome C release[J]. J Biol Chem,2007,282(25) : 18057-18068.
  • 7Urso ML, Clarkson PM. Oxidative stress, exercise, and antioxidant supplementation[J].Toxicology, 2003,189 (1-2) : 41-54.
  • 8Abdel-Zaher AO, Abdel-Rahman MM. Lithium chloride- induced cardiovascular changes in rabbits are mediated by adenosine triphosphate-sensitive potassium channels [J].Pharmacol Res, 1999,39 (4) : 275-282.
  • 9Mori S, Zanardi R, Popoli M, et al. Inhibitory effect of lithium on cAMP dependent phosphorylation system[J].Life Sci, 1996,59(9) :99-104.
  • 10Savio-Galimberti E, Ponce-Hornos JE. Effects of caffeine, verapamil,lithium,and KB-R7943 on mechanics and energetics of rat myocardial bigeminies [J]. Am J Physiol Heart Cire Physiol, 2006,290(2) : 613-623.

共引文献2

同被引文献61

引证文献6

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部